The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system.
about
Metal-Based Nanoparticles and the Immune System: Activation, Inflammation, and Potential ApplicationsInflammation and the two-hit hypothesis of schizophrenia.Perioperative treatment with the new synthetic TLR-4 agonist GLA-SE reduces cancer metastasis without adverse effects.Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen-like Particles Synergistically Enhances Innate and Adaptive Immune Responses.Altered innate immune development in HIV-exposed uninfected infants.Needle-Free Delivery of Acetalated Dextran-Encapsulated AR-12 Protects Mice from Francisella tularensis Lethal Challenge.Combined TLR7/8 and TLR9 ligands potentiate the activity of a Schistosoma japonicum DNA vaccine.Characterization of Innate Responses Induced by PLGA Encapsulated- and Soluble TLR Ligands In Vitro and In Vivo in Chickens.Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvantCpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST.Innate immune protection against infectious diseases by pulmonary administration of a phospholipid-conjugated TLR7 ligand.The genetics of innate immunity sensors and human disease.Vaccine adjuvant uses of poly-IC and derivatives.Modes of action of TLR7 agonists in cancer therapy.Toll gates: An emerging therapeutic target.Topical treatment of basal cell carcinoma with the immune response modifier imiquimod.Advances in Antiviral Therapies Targeting Toll-like Receptors.An Enzyme-Directed Imidazoquinoline for Cancer Immunotherapy.An iron oxide nanocarrier for dsRNA to target lymph nodes and strongly activate cells of the immune system.Specific activation of the TLR1-TLR2 heterodimer by small-molecule agonists.[Stimulating Type I interferon response with small molecules: revival of an old idea].Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer.Adjuvant-Loaded Spiky Gold Nanoparticles for Activation of Innate Immune Cells.Direct and Intestinal Epithelial Cell-Mediated Effects of TLR8 Triggering on Human Dendritic Cells, CD14+CD16+ Monocytes and γδ T Lymphocytes.TLR7 agonists display potent antiviral effects against norovirus infection via innate stimulation.Factors Influencing the Differentiation of Human Monocytic Myeloid-Derived Suppressor Cells Into Inflammatory Macrophages.TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy
P2860
Q28396375-173DB7CE-E353-4BC5-A18E-FF71EC680584Q30422062-E0D9966B-76B7-4DA0-B53E-45CD999B7AFAQ30700261-81C9F642-4952-411F-903A-A58BEF33B07FQ33746872-3C87D991-6496-43A6-8B37-4CC31307EA76Q34098338-754456A7-6058-4C87-A5C8-A74E11262823Q34509909-7E2673BF-0E51-4E5A-8D9A-06DA80796F0BQ34675128-A8B1AEC3-0079-4535-B563-746BCCFDB440Q36238084-439B70D2-655F-4EEB-842D-6EB23A7F8CB0Q37198471-56C8412B-D4A5-4AAD-8B3E-0741F8A8362DQ37565174-6ED574C9-BE39-42A9-9241-A07791B7239EQ37678709-54CD856F-C345-412B-9386-F26DE52E9157Q38097500-39D4192D-7959-419D-9768-7943C2AC7778Q38259510-7705C006-FD0B-447B-8652-73EF841F060DQ38271879-F6A12551-E0D2-406D-82E3-32C09409E8F6Q38333830-1CFA190D-AF61-47FB-98FC-E2D919541BBCQ38602867-2CEEB7C3-EAF0-4FAF-8E1A-03E023BB7ACEQ38733975-63161D77-AF78-4883-A157-D283F3E7EDF2Q38741706-80641091-B1A2-41C1-80BF-930BE7965BC3Q38966014-E21FC896-1B1F-4CAA-A2AC-464ED2EE4F62Q38992678-08DEAE78-A914-46CD-AC3C-82B37DD74C7EQ40932056-CCA29FC2-973C-4CA7-959A-C413229E778CQ41886564-38580707-6EF5-4DC6-A687-AA5D2F186C6FQ47226216-C4B65665-9324-40C8-9412-B6F2CBD4CD3BQ47556910-30D296CD-15F0-4C53-8C92-25EFA4A8C999Q51741116-81AD2E05-018B-436E-B9AD-04D52F6943C8Q55040962-AA5A1329-956B-4A01-B730-5481FA6B1D5BQ57826568-8E3CE9F6-DD58-4C50-9B0F-FA591FFFEDD1
P2860
The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system.
@ast
The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system.
@en
type
label
The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system.
@ast
The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system.
@en
prefLabel
The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system.
@ast
The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system.
@en
P2860
P356
P1476
The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system
@en
P2093
Abbi L Engel
Hailing Lu
P2860
P304
P356
10.1586/ECP.11.5
P407
P577
2011-03-01T00:00:00Z